Company Formation
We work with founders and seed investors to shape promising science into a business ready for financing and led through what comes next, not just the next round.
Financing Strategy and Positioning
We help management teams and boards develop strategic narratives around realistic milestones relevant to existing and prospective investors.
Corporate Direction
We advise companies regarding asset emphasis, partnership structuring, and corporate governance, emphasizing value creation for all stakeholders.
Advisory Focus
About Bersot Consulting
I'm Ross Bersot. I founded and led Reset Therapeutics as President and CEO for nearly a decade, building a drug discovery company around the biology of circadian rhythms from concept to the clinic. I was a Managing Director and Venture Partner at Bay City Capital, where I invested in and developed emerging businesses harnessing novel biological insights. Earlier, I was an analyst at Jackson Square Partners, a market-neutral hedge fund. I hold a degree in Economics from UCLA and I am a CFA charterholder.
My breadth of experience allows me to anticipate challenges, identify opportunities, and deliver solutions tailored to a company’s stage and goals. I have evaluated, structured, and supported science-driven companies across various stages of growth and development, bringing an operator’s perspective and an investor’s discipline to a team's decision-making processes.
Our advisory approach is grounded in analytical rigor and a practical understanding of how scientific ambition intersects with capital constraints and market expectations. Engagements are selective and conducted with discretion, with the objective of achieving durable value creation.
Engagement Model
We undertake a limited number of advisory mandates at any given time in order to preserve focus and depth of engagement.
Each mandate is outcome-oriented and structured around clearly defined strategic objectives. Engagements may span company formation, investor positioning, capital strategy, asset prioritization, partnership structuring, and governance alignment. We collaborate directly with management teams, boards, and investors to reinforce discipline and internal coherence when multiple avenues to long-term value creation present a variety of potential outcomes for various stakeholders.
All mandates are conducted with discretion and confidentiality. Engagement terms are structured to align incentives and preserve independence of judgment.
Start a Conversation
Prospective partners are invited to provide a brief overview of your organization and the context in which we may provide assistance.